In contrast, expression of the TREM2 myeloid signature was elevated in BIT-low BCC myeloid cells (Supplementary Figs. 4g, 5a), an observation consistent with our previous work on drug-sensitive BCC epithelium16. Here, TREM2 is linked to skin basal cell carcinoma.